Secukinumab does not impair the immunogenic response to the influenza vaccine in patients | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Treatments

Short report

Secukinumab does not impair the immunogenic response to the influenza vaccine in patients

Online download statistics by month:

Online download statistics by month: September 2019 to June 2022

	Abstract	Full	Pdf
Sep 2019	116	115	78
Oct 2019	95	94	48
Nov 2019	41	42	29
Dec 2019	30	30	16
Jan 2020	37	35	19
Feb 2020	35	35	14
Mar 2020	57	57	17
Apr 2020	35	34	8
May 2020	26	20	21
Jun 2020	30	29	37
Jul 2020	39	38	8
Aug 2020	25	23	11
Sep 2020	71	63	16
Oct 2020	117	115	16
Nov 2020	80	79	18
Dec 2020	106	103	23
Jan 2021	128	127	42
Feb 2021	49	49	20
Mar 2021	72	66	16
Apr 2021	79	78	21
May 2021	98	93	9
Jun 2021	80	78	18
Jul 2021	45	44	9
Aug 2021	78	77	8
Sep 2021	63	62	11
Oct 2021	83	79	29
Nov 2021	39	37	18
Dec 2021	45	45	3
Jan 2022	43	44	14
Feb 2022	38	40	4
Mar 2022	41	43	9
Apr 2022	34	34	9
May 2022	35	35	12
Jun 2022	43	44	6
Total	2033	1987	637